Latest Research in Adipokines, Inflammation, and Metabolic Diseases

Top Research Topics in Adipokines, Inflammation, and Metabolic Diseases

• Diabetes, Cardiovascular Risks, and Lipoproteins — 9 papers
• Diabetes Treatment and Management — 7 papers
• Adipokines, Inflammation, and Metabolic Diseases — 4 papers
• Chronic Kidney Disease and Diabetes — 3 papers
• HIV-related health complications and treatments — 2 papers
• Bone health and osteoporosis research — 2 papers
• Diabetes and associated disorders — 1 papers
• Lipid metabolism and disorders — 1 papers
• Fatty Acid Research and Health — 1 papers
• Cardiac Health and Mental Health — 1 papers

Highest-Cited Papers

1. Subclinical cardiac involvement during diabetic ketoacidosis at type 1 diabetes onset in youth: biomarker elevation, altered diastolic filling, and reduced global longitudinal strain: a prospective cohort study
2. Clinical Utility of the Atherogenic Plasma Index for Identifying Atherogenic Dyslipidemia: A Large Cross-Sectional Analysis Stratified by Sex and Thyroid Status
3. Association between Glycemic Control and Survival in Patients with Type 2 Diabetes on Peritoneal Dialysis
4. A Novel Triglyceride- and Cholesterol-Enriched Lipoprotein(a) Phenotype in Moderate Hypertriglyceridemia
5. 0053Fatty Acid Remodeling Links the Atherogenic Index of Plasma to Coronary Artery Disease Severity
6. Depression Symptoms and Advanced Cardiovascular–Kidney–Metabolic Syndrome in U.S. Adults: The Moderating Role of Sex
7. Metabolic obesity phenotypes and degenerative valvular heart disease: A cohort study
8. Predictive value of triglyceride-glucose-related indices for major adverse cardiovascular events in individuals with cardiovascular-kidney-metabolic syndrome stage 0–3: a prospective cohort study based on CHARLS
9. Association of Inpatient Diabetes Specialist Consultation with Clinical Outcomes in Patients with Diabetes Hospitalized for Lower Respiratory Tract Infections: A Retrospective Cohort Study
10. Cardiovascular Effects of Chronic GIPR and GLP-1R Agonism in Lean and Diet-Induced Obese Mice: Sex Differences and Dose-Dependent Remodeling
11. Association of high remnant cholesterol inflammatory index reversal with subsequent cardiovascular disease in middle-aged and older Chinese adults: a 2015-wave landmark cohort analysis of CHARLS
12. Establishing non-fasting lipid reference intervals and clinical decision limits in a senegalese adult cohort
13. Cumulative average metabolic indices and cardiovascular disease risk: additive predictive effects and partial mediating role of intrinsic capacity in early-stage CKM syndrome
14. Assessing the Association Between GLP-1 Receptor Agonists and Diabetic Foot Complications Using Real-World Pharmacovigilance Database and Mendelian Randomization
15. The Nonlinear Association Between Adipose Tissue Insulin Resistance and Remnant Cholesterol in Chinese Adults: A Cross-Sectional Study
16. CARDIOVASCULAR EFFECTS OF INCRETIN RECEPTOR AGONISTS: BEYOND GLYCEMIC CONTROL
17. Measures of obesity and first atherosclerotic cardiovascular events in stage 0 cardiovascular-kidney-metabolic syndrome: Tehran lipid and glucose study
18. Multidomain Cardiorenal-Metabolic Abnormalities Despite HbA1c
19. Dyslipidaemia: Pathophysiology, Epidemiology, Diagnostic Advances, and Emerging Therapeutic Strategies
20. Joint association of five insulin resistance indices and frailty index with incident cardiometabolic multimorbidity in individuals with cardiovascular–kidney–metabolic syndrome stages 0–3: a prospective cohort study